m-Resist Vision
mRESIST aims to implement a model of analysis in order to move forward in understanding resistant schizophrenia.
m-Resist is a research & innovation project funded by the EU under the Horizon 2020 program in the domain of PHC-26-2014: Self-management of health and disease: citizen engagement and mHealth. The project started 1st of January 2015 and will run for a period of thirty-six months. The primary objective of the mResist project is to develop a therapeutic program that draws on the support of mobile devices to actively involve patients with treatment-resistant schizophrenia, to make them capable of self-managing their own illness, as well as to support their careers.
No front page content has been created yet.
See the latest news of mResist project…
On 2 June and 3 June 2015, the EC co-funded project m-RESIST had its 2nd Plenary Meeting in Barcelona.
Meet some of our project partners from the kick-off meeting who tell us more about their expectations of the m-RESIST project.
Consortium has submitted mResist’s presentation to Euro Global Summit and Medicare Expo on Psychiatry
On 28 January and 29 January 2015, the EC co-funded project m-RESIST had its kick-off meeting in Barcelona, Spain.